Ultralife Corp (ULBI) 4.76 $ULBI
Ultralife posts 1Q profit
Automated Insights - Thu Apr 28, 9:52AM CDT
NEWARK, N.Y. (AP) _ Ultralife Corp. (ULBI) on Thursday reported first-quarter net income of $299,000.
ULBI: 4.76 (-0.04)
Ultralife Corporation Reports First Quarter Results
GlobeNewswire - Thu Apr 28, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) reported operating income of $0.5 million on revenue of $20.8 million for the first quarter ended March 27, 2016. For the first quarter of 2015, the Company reported operating income of $0.8 million on revenue of $19.2 million. Included in results for the first quarter of 2016 is $0.3 million of non-recurring costs and purchase accounting adjustments related to the acquisition of Accutronics Ltd., which the Company completed on January 13, 2016.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report First Quarter Results on April 28, 2016
GlobeNewswire - Thu Apr 14, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 27, 2016 before the market opens on Thursday, April 28, 2016.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report Fourth Quarter Results on February 11, 2016
GlobeNewswire - Thu Jan 28, 6:00AM CST
Ultralife Corporation (NASDAQ:ULBI) will report its fourth quarter results for the period ended December 31, 2015 before the market opens on Thursday, February 11, 2016.
ULBI: 4.76 (-0.04)
Ultralife Corporation Acquires Accutronics Ltd. for Approximately $11.0 Million
GlobeNewswire - Wed Jan 13, 4:45PM CST
Ultralife Corporation (NASDAQ:ULBI) has acquired all of the outstanding shares of Accutronics Ltd., for £7.575 million (approximately $11.0 million) in cash, subject to customary working capital and net cash/debt adjustments. Based in Newcastle-under-Lyme, U.K., Accutronics Ltd. is a leading independent designer and manufacturer of smart batteries and charger systems for high-performance, feature-laden portable and handheld electronic devices.
ULBI: 4.76 (-0.04)
Equity Market Movement at a Glance - Research on Ultralife, First Acceptance, Titan Pharmaceuticals and Gencor Industries
ACCESSWIRE - Wed Dec 02, 7:15AM CST
NEW YORK, NY / ACCESSWIRE / December 02, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ultralife Corp. (NASDAQ: ULBI), First Acceptance Corp. (NYSE: FAC), Titan Pharmaceuticals Inc. (NASDAQ: TTNP) and Gencor Industries Inc. (NASDAQ: GENC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ULBI: 4.76 (-0.04), GENC: 15.30 (+0.30), TTNP: 5.34 (-0.15), FAC: 1.24 (+0.02)
Recent Technical and Business Updates - Research on FormFactor, Calithera Biosciences, Ocular Therapeutix and Ultralife
ACCESSWIRE - Mon Nov 02, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / November 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: FormFactor, Inc (NASDAQ: FORM), Calithera Biosciences, Inc. (NASDAQ: CALA), Ocular Therapeutix, Inc. (NASDAQ: OCUL) and Ultralife Corporation (NASDAQ: ULBI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
ULBI: 4.76 (-0.04), FORM: 9.72 (+0.17), CALA: 3.45 (-0.18), OCUL: 5.76 (-0.18)
Ultralife Corporation Reports Third Quarter Results
GlobeNewswire - Thu Oct 29, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) reported operating income of $1.2 million on revenue of $19.0 million for the quarter ended September 27, 2015. For the third quarter of 2014, the Company reported an operating loss of $0.1 million on revenue of $16.1 million.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report Third Quarter Results on October 29, 2015
GlobeNewswire - Thu Oct 15, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) will report its third quarter results for the period ended September 27, 2015 before the market opens on Thursday, October 29, 2015.
ULBI: 4.76 (-0.04)
Ultralife Corporation Awarded $8.2 Million Communications Systems Contract
GlobeNewswire - Tue Sep 01, 8:14AM CDT
Ultralife Corporation (NASDAQ:ULBI) has been awarded a contract valued at approximately $8.2 million to supply its Soldier Radio Waveform ("SRW"
Vehicle Installed Power Enhanced Rifleman Applique ("VIPER" systems to Thales Defense & Security, Inc., a global leader in the development, manufacture, and support of combat-proven, software-defined radio (SDR) equipment, for the U.S. Army. The majority of the shipments are expected to occur in 2016 with modest initial shipments beginning in late 2015.
ULBI: 4.76 (-0.04)
Ultralife Corporation Reports Second Quarter Results
GlobeNewswire - Thu Jul 30, 6:02AM CDT
Ultralife Corporation (NASDAQ:ULBI) reported operating income of $0.8 million on revenue of $19.0 million for the quarter ended June 28, 2015. For the second quarter of 2014, the Company reported an operating loss of $1.3 million on revenue of $15.2 million.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report Second Quarter Results on July 30, 2015
GlobeNewswire - Thu Jul 16, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) will report its second quarter results for the period ended June 28, 2015 before the market opens on Thursday, July 30, 2015.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report First Quarter Results on April 30, 2015
GlobeNewswire - Thu Apr 16, 6:38AM CDT
Ultralife Corporation (Nasdaq:ULBI) will report its first quarter results for the period ended March 29, 2015 before the market opens on Thursday, April 30, 2015.
ULBI: 4.76 (-0.04)
Ultralife Corporation Reports Fourth Quarter Results
GlobeNewswire - Thu Feb 12, 6:16AM CST
Ultralife Corporation (Nasdaq:ULBI) reported operating income of $1.0 million on revenue of $19.9 million for the quarter ended December 31, 2014. For the fourth quarter of 2013, the Company reported operating income of $0.2 million on revenue of $20.2 million.
ULBI: 4.76 (-0.04)
Ultralife posts 1Q profit
Automated Insights - Thu Apr 28, 9:52AM CDT
NEWARK, N.Y. (AP) _ Ultralife Corp. (ULBI) on Thursday reported first-quarter net income of $299,000.
ULBI: 4.76 (-0.04)
Ultralife Corporation Reports First Quarter Results
GlobeNewswire - Thu Apr 28, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) reported operating income of $0.5 million on revenue of $20.8 million for the first quarter ended March 27, 2016. For the first quarter of 2015, the Company reported operating income of $0.8 million on revenue of $19.2 million. Included in results for the first quarter of 2016 is $0.3 million of non-recurring costs and purchase accounting adjustments related to the acquisition of Accutronics Ltd., which the Company completed on January 13, 2016.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report First Quarter Results on April 28, 2016
GlobeNewswire - Thu Apr 14, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended March 27, 2016 before the market opens on Thursday, April 28, 2016.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report Fourth Quarter Results on February 11, 2016
GlobeNewswire - Thu Jan 28, 6:00AM CST
Ultralife Corporation (NASDAQ:ULBI) will report its fourth quarter results for the period ended December 31, 2015 before the market opens on Thursday, February 11, 2016.
ULBI: 4.76 (-0.04)
Ultralife Corporation Acquires Accutronics Ltd. for Approximately $11.0 Million
GlobeNewswire - Wed Jan 13, 4:45PM CST
Ultralife Corporation (NASDAQ:ULBI) has acquired all of the outstanding shares of Accutronics Ltd., for £7.575 million (approximately $11.0 million) in cash, subject to customary working capital and net cash/debt adjustments. Based in Newcastle-under-Lyme, U.K., Accutronics Ltd. is a leading independent designer and manufacturer of smart batteries and charger systems for high-performance, feature-laden portable and handheld electronic devices.
ULBI: 4.76 (-0.04)
Equity Market Movement at a Glance - Research on Ultralife, First Acceptance, Titan Pharmaceuticals and Gencor Industries
ACCESSWIRE - Wed Dec 02, 7:15AM CST
NEW YORK, NY / ACCESSWIRE / December 02, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Ultralife Corp. (NASDAQ: ULBI), First Acceptance Corp. (NYSE: FAC), Titan Pharmaceuticals Inc. (NASDAQ: TTNP) and Gencor Industries Inc. (NASDAQ: GENC). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ULBI: 4.76 (-0.04), GENC: 15.30 (+0.30), TTNP: 5.34 (-0.15), FAC: 1.24 (+0.02)
Recent Technical and Business Updates - Research on FormFactor, Calithera Biosciences, Ocular Therapeutix and Ultralife
ACCESSWIRE - Mon Nov 02, 7:30AM CST
NEW YORK, NY / ACCESSWIRE / November 2, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: FormFactor, Inc (NASDAQ: FORM), Calithera Biosciences, Inc. (NASDAQ: CALA), Ocular Therapeutix, Inc. (NASDAQ: OCUL) and Ultralife Corporation (NASDAQ: ULBI). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
ULBI: 4.76 (-0.04), FORM: 9.72 (+0.17), CALA: 3.45 (-0.18), OCUL: 5.76 (-0.18)
Ultralife Corporation Reports Third Quarter Results
GlobeNewswire - Thu Oct 29, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) reported operating income of $1.2 million on revenue of $19.0 million for the quarter ended September 27, 2015. For the third quarter of 2014, the Company reported an operating loss of $0.1 million on revenue of $16.1 million.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report Third Quarter Results on October 29, 2015
GlobeNewswire - Thu Oct 15, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) will report its third quarter results for the period ended September 27, 2015 before the market opens on Thursday, October 29, 2015.
ULBI: 4.76 (-0.04)
Ultralife Corporation Awarded $8.2 Million Communications Systems Contract
GlobeNewswire - Tue Sep 01, 8:14AM CDT
Ultralife Corporation (NASDAQ:ULBI) has been awarded a contract valued at approximately $8.2 million to supply its Soldier Radio Waveform ("SRW"
Vehicle Installed Power Enhanced Rifleman Applique ("VIPER" systems to Thales Defense & Security, Inc., a global leader in the development, manufacture, and support of combat-proven, software-defined radio (SDR) equipment, for the U.S. Army. The majority of the shipments are expected to occur in 2016 with modest initial shipments beginning in late 2015. ULBI: 4.76 (-0.04)
Ultralife Corporation Reports Second Quarter Results
GlobeNewswire - Thu Jul 30, 6:02AM CDT
Ultralife Corporation (NASDAQ:ULBI) reported operating income of $0.8 million on revenue of $19.0 million for the quarter ended June 28, 2015. For the second quarter of 2014, the Company reported an operating loss of $1.3 million on revenue of $15.2 million.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report Second Quarter Results on July 30, 2015
GlobeNewswire - Thu Jul 16, 6:00AM CDT
Ultralife Corporation (NASDAQ:ULBI) will report its second quarter results for the period ended June 28, 2015 before the market opens on Thursday, July 30, 2015.
ULBI: 4.76 (-0.04)
Ultralife Corporation to Report First Quarter Results on April 30, 2015
GlobeNewswire - Thu Apr 16, 6:38AM CDT
Ultralife Corporation (Nasdaq:ULBI) will report its first quarter results for the period ended March 29, 2015 before the market opens on Thursday, April 30, 2015.
ULBI: 4.76 (-0.04)
Ultralife Corporation Reports Fourth Quarter Results
GlobeNewswire - Thu Feb 12, 6:16AM CST
Ultralife Corporation (Nasdaq:ULBI) reported operating income of $1.0 million on revenue of $19.9 million for the quarter ended December 31, 2014. For the fourth quarter of 2013, the Company reported operating income of $0.2 million on revenue of $20.2 million.
ULBI: 4.76 (-0.04)
